Money
Filter News
Found 73,636 articles
-
The SEC said that Yum China, BeiGene, Zai Lab, HutchMed and ACM Research are all at risk if they do not give U.S. regulators access to their audit records.
-
Flagship Pioneering announced the launch of Sonata Therapeutics. The fledgling company was created by combining two Flagship companies, Inzen Therapeutics and Cygnal Therapeutics.
-
Greece’s Health Minister Thanos Plevris announced plans to sue Novartis over what he alleges are illegal practices. In addition to demanding compensation, the country is implementing a three-point plan.
-
Applied Molecular Transport (AMT) provided a strategy update on Wednesday. Part of the update includes reducing its workforce by about 40% and funneling resources into its lead program.
-
Possibly reflecting the current Bear market, Berkshire Hathaway has walked away from its stake in both AbbVie and BMS.
-
Recent funding saw support for a platform that selectively degrades DNA, software to help read mammograms and a company using corn genetics to develop cancer-targeting viruses.
-
We surveyed thousands of industry professionals to get the most current, accurate salary statistics. Read on to find out the top-paying jobs in each sector.
-
Laekna Therapeutics Raises $61 Million in Series D financing
5/18/2022
Laekna Therapeutics (" Laekna "), a clinical-stage global biotechnology company dedicated to developing next generation medicines to treat cancer and liver diseases, announced that it has raised $61 million in Series D financing led by CS Capital with support from Worldstar, and Infinity Capital.
-
Locus Biosciences Announces $35 Million Financing
5/18/2022
Locus Biosciences, Inc. today announced that it completed a $35 million financing which included a Series B equity financing and conversion of an earlier convertible note.
-
CND Life Sciences Awarded NIH SBIR Grant to Study Novel Skin Biopsy Test for Dementias
5/18/2022
CND Life Sciences, an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, has been awarded a $2.4 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH).
-
Calliditas Therapeutics: Interim Report Q1, 2022
5/18/2022
During the first quarter Calliditas launched its first commercial product, TARPEYO, in the US, supported by 40 experienced specialty sales executives who were trained and in the field in late January.
-
SwanBio Therapeutics Announces $56 Million Series B Financing to Advance Novel Gene Therapies for Neurological Conditions
5/18/2022
SwanBio Therapeutics, a gene therapy company advancing adeno-associated virus -based therapies for the treatment of devastating, inherited neurological conditions, announced the completion of a $56 million Series B financing round, led by founding investors Syncona Limited and Mass General Brigham Ventures.
-
Interim report January 1 - March 31, 2022
5/18/2022
In the first quarter of 2022, license revenue rose 35 percent and support revenue rose 24 percent. Operating profit amounted to SEK 30 M.
-
RQ Biotechnology has officially launched, with the financial backing of AstraZeneca. The move strategically increases the availability of monoclonal antibodies at a time of ever-increasing demand.
-
Sabin Vaccine Institute Receives up to $6.3 Million from CEPI for Dose-Optimizing COVID-19 Vaccine Clinical Trial
5/17/2022
The Sabin Vaccine Institute was awarded up to $6.3 million from the Coalition for Epidemic Preparedness Innovations (CEPI) for a clinical trial to evaluate the immunogenicity and safety of lower, fractional doses of registered COVID-19 vaccines used as a booster dose.
-
Cynosure Announces $60 Million Follow-on Investment from Clayton, Dubilier & Rice to Accelerate Growth
5/17/2022
Cynosure, LLC, a leader in medical aesthetics systems and technologies, announced today a new investment of $60 million from lead investor Clayton, Dubilier & Rice.
-
Vertex Announces $50 Million Commitment to Health Equity With Three Initial Grants
5/17/2022
Vertex Pharmaceuticals Incorporated announced that Vertex and the Vertex Foundation, a nonprofit charitable foundation, have committed $50 million over five years to clinical trial diversity, access to quality care, and education of our health care workforce.
-
International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022
5/17/2022
International Stem Cell Corporation, a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, provided a business update and financial results for the three months ended March 31, 2022.
-
EDAP Reports First Quarter 2022 Results
5/17/2022
EDAP TMS SA, a global leader in robotic energy-based therapies, announced unaudited financial results for the first quarter 2022.
-
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
5/17/2022
Vyriad, Inc. announced $29.5M in new funding led by Mr. Harry Stine of Stine Seed Farms, Inc. with participation from existing investors.